Monoclonal antibodies (mAbs) have become indispensable in biomedicine, revolutionising our approach to understanding and addressing complex biological processes. By providing researchers with a reliable and precise tool, mAbs contribute significantly to the advancement of our knowledge about the mechanisms involved in tumour transformation and development. Beyond their fundamental role in laboratory research, mAbs play a crucial part in cancer detection and therapy, offering practical solutions for its diagnosis and treatment.
The Monoclonal Antibodies Unit provides CNIO Research Groups with the “à la carte” generation of mAbs using hybridoma technology. We are highly specialised in the production of mouse and rat monoclonal antibodies. The Unit also offers mAb characterisation and validation, medium scale mAb production, as well as a service of Mycoplasma testing for the cell culture facility.
Open Access